20-Avp-786-306
Research payments
$1,137,552
Through program year 2022, $1,137,552 in research payments was reported against 20-Avp-786-306, across 277 payments, paid by Avanir Pharmaceuticals, Inc..
- Paid by
- Avanir Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $271,957 | 156 |
| 2021 | Research | $817,775 | 108 |
| 2020 | Research | $47,820 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jose Cevallos West Palm Beach, FL Named on 43 payments
- Kore Liow Honolulu, HI Named on 22 payments
- Ernesto Diaz Miami, FL Named on 20 payments
- Kent Smalley Oklahoma City, OK Named on 11 payments
- Franklin Saumell Miami, FL Named on 9 payments
- German Alvarez Tampa, FL Named on 8 payments
- Sandeep Vaid Peachtree City, GA Named on 7 payments
- Maria Kataki Columbus, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.